89 related articles for article (PubMed ID: 34687597)
1. Lipase elevation in serum of COVID-19 patients: frequency, extent of increase and clinical value.
Caruso S; Aloisio E; Dolci A; Panteghini M
Clin Chem Lab Med; 2022 Jan; 60(1):135-142. PubMed ID: 34687597
[TBL] [Abstract][Full Text] [Related]
2. Hyperlipasemia in absence of acute pancreatitis is associated with elevated D-dimer and adverse outcomes in COVID 19 disease.
Ahmed A; Fisher JC; Pochapin MB; Freedman SD; Kothari DJ; Shah PC; Sheth SG
Pancreatology; 2021 Jun; 21(4):698-703. PubMed ID: 33741267
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Outcomes in COVID-19 Patients With Varying Degrees of Hyperlipasemia.
Benias PC; Inamdar S; Wee D; Liu Y; Buscaglia JM; Satapathy SK; Trindade AJ;
Pancreas; 2021 Oct; 50(9):1310-1313. PubMed ID: 34860817
[TBL] [Abstract][Full Text] [Related]
4. Lipase elevation on admission predicts worse clinical outcomes in patients with COVID-19.
Kiyak M; Düzenli T
Pancreatology; 2022 Jun; 22(5):665-670. PubMed ID: 35537935
[TBL] [Abstract][Full Text] [Related]
5. Lipase Elevation in Patients With COVID-19.
McNabb-Baltar J; Jin DX; Grover AS; Redd WD; Zhou JC; Hathorn KE; McCarty TR; Bazarbashi AN; Shen L; Chan WW
Am J Gastroenterol; 2020 Aug; 115(8):1286-1288. PubMed ID: 32496339
[TBL] [Abstract][Full Text] [Related]
6. Development of pancreatic injuries in the course of COVID-19.
Akkus C; Yilmaz H; Mizrak S; Adibelli Z; Akdas O; Duran C
Acta Gastroenterol Belg; 2020; 83(4):585-592. PubMed ID: 33321015
[TBL] [Abstract][Full Text] [Related]
7. PANCREATITIS OR NOT?--Elevated lipase and amylase in ICU patients.
Muniraj T; Dang S; Pitchumoni CS
J Crit Care; 2015 Dec; 30(6):1370-5. PubMed ID: 26411523
[TBL] [Abstract][Full Text] [Related]
8. Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19.
Myhre PL; Prebensen C; Strand H; Røysland R; Jonassen CM; Rangberg A; Sørensen V; Søvik S; Røsjø H; Svensson M; Berdal JE; Omland T
Circulation; 2020 Dec; 142(22):2128-2137. PubMed ID: 33058695
[TBL] [Abstract][Full Text] [Related]
9. Does Hyperlipasemia Predict Worse Clinical Outcomes in COVID-19? A Multicenter Retrospective Cohort Study.
Singh RR; Chhabra P; Kumta NA
J Clin Gastroenterol; 2022 Mar; 56(3):e227-e231. PubMed ID: 34294655
[TBL] [Abstract][Full Text] [Related]
10. Hyperlipasemia and Potential Pancreatic Injury Patterns in COVID-19: A Marker of Severity or Innocent Bystander?
Goyal H; Sachdeva S; Perisetti A; Mann R; Inamdar S; Tharian B
Gastroenterology; 2021 Feb; 160(3):946-948.e2. PubMed ID: 33129845
[No Abstract] [Full Text] [Related]
11. Clinical significance of increased lipase levels on admission to the ICU.
Manjuck J; Zein J; Carpati C; Astiz M
Chest; 2005 Jan; 127(1):246-50. PubMed ID: 15653991
[TBL] [Abstract][Full Text] [Related]
12. High lipasemia is frequent in Covid-19 associated acute respiratory distress syndrome.
Rasch S; Herner A; Schmid RM; Huber W; Lahmer T
Pancreatology; 2021 Jan; 21(1):306-311. PubMed ID: 33277183
[TBL] [Abstract][Full Text] [Related]
13. Low Frequency of Acute Pancreatitis in Hospitalized COVID-19 Patients.
Troncone E; Salvatori S; Sena G; De Cristofaro E; Alfieri N; Marafini I; Paganelli C; Argirò R; Giannarelli D; Monteleone G; Del Vecchio Blanco G
Pancreas; 2021 Mar; 50(3):393-398. PubMed ID: 33835971
[TBL] [Abstract][Full Text] [Related]
14. CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study.
Lorè NI; De Lorenzo R; Rancoita PMV; Cugnata F; Agresti A; Benedetti F; Bianchi ME; Bonini C; Capobianco A; Conte C; Corti A; Furlan R; Mantegani P; Maugeri N; Sciorati C; Saliu F; Silvestri L; Tresoldi C; ; Ciceri F; Rovere-Querini P; Di Serio C; Cirillo DM; Manfredi AA
Mol Med; 2021 Oct; 27(1):129. PubMed ID: 34663207
[TBL] [Abstract][Full Text] [Related]
15. Serum amylase and lipase in the evaluation of acute abdominal pain.
Chase CW; Barker DE; Russell WL; Burns RP
Am Surg; 1996 Dec; 62(12):1028-33. PubMed ID: 8955242
[TBL] [Abstract][Full Text] [Related]
16. A bimodal pattern of the onset of COVID-19 related acute pancreatitis supports both the cytotoxic and immune-related pathogenesis - a systematic review.
Bircakova B; Bruha R; Lambert L; Grusova G; Michalek P; Burgetova A
Scand J Gastroenterol; 2021 Jul; 56(7):870-873. PubMed ID: 33989101
[TBL] [Abstract][Full Text] [Related]
17. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
[TBL] [Abstract][Full Text] [Related]
18. Elevated amylase and lipase levels in the neurosurgery intensive care unit.
Lee CC; Chung WY; Shih YH
J Chin Med Assoc; 2010 Jan; 73(1):8-14. PubMed ID: 20103485
[TBL] [Abstract][Full Text] [Related]
19. Lipase activity in serum measured with Ektachem is often increased in nonpancreatic disorders.
Tetrault GA
Clin Chem; 1991 Mar; 37(3):447-51. PubMed ID: 1706233
[TBL] [Abstract][Full Text] [Related]
20. Patients With Coronavirus Disease 2019 Interstitial Pneumonia Exhibit Pancreatic Hyperenzymemia and Not Acute Pancreatitis.
Pezzilli R; Centanni S; Mondoni M; Rinaldo RF; Davì M; Stefanelli R; Melzi d'Eril G; Barassi A
Pancreas; 2021 May-Jun 01; 50(5):732-735. PubMed ID: 34016891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
